A New Era in Continuous Glucose Monitoring: Food and Drug Administration Creates a New Category of Factory-Calibrated Nonadjunctive, Interoperable Class II Medical Devices
Authors:
- 1 June 2018
- journal article
- editorial
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 20 (6) , 391-394
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Performance Comparison of the Medtronic Sof-Sensor and Enlite Glucose Sensors in Inpatient Studies of Individuals with Type 1 DiabetesDiabetes Technology & Therapeutics, 2013
- Use of Continuous Glucose Monitoring in Subjects With Type 1 Diabetes on Multiple Daily Injections Versus Continuous Subcutaneous Insulin Infusion TherapyDiabetes Care, 2011
- Time lag characterization of two continuous glucose monitoring systemsDiabetes Research and Clinical Practice, 2010
- Feasibility of 10-Day Use of a Continuous Glucose-Monitoring System in Adults With Type 1 DiabetesDiabetes Care, 2009
- Evaluation of Urinary Biomarkers for Coronary Artery Disease, Diabetes, and Diabetic Kidney DiseaseDiabetes Technology & Therapeutics, 2009
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesNew England Journal of Medicine, 2008
- Continuous Home Monitoring of GlucoseDiabetes Care, 2007
- Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patientsDiabetes Research and Clinical Practice, 2007
- Relationship of Fasting and Hourly Blood Glucose Levels to HbA1c ValuesDiabetes Care, 2006
- Continuous Subcutaneous Glucose Monitoring in Children With Type 1 DiabetesPediatrics, 2001